BlossomHill Therapeutics, Inc. (BLSM) vs Shattuck Labs, Inc. (STTK)
A side-by-side comparison of BlossomHill Therapeutics, Inc. and Shattuck Labs, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BLSM
BlossomHill Therapeutics, Inc.
$17.29HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
STTK
Shattuck Labs, Inc.
$5.86HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BLSM vs STTK
growth of $100 · dividends reinvested · last 1yBLSM +24.6% (+24.6%/yr)STTK -11.8% (-11.8%/yr)BLSM compounded faster over this window
BLSM STTK
BLSM vs STTK: by the numbers
- •STTK is the larger company ($530M vs $503M market cap).
- •Both run net losses; BLSM's is the smaller (0.00% vs -5256.80% net margin).
Metrics side by side
Valuation
| Metric | BLSM | STTK |
|---|---|---|
| P/S ratio | N/A | 529.58 |
| P/B ratio | N/A | 2.51 |
Profitability
| Metric | BLSM | STTK |
|---|---|---|
| Gross margin | 0.00% | -195.10% |
| Operating margin | 0.00% | -5150.80% |
| Net margin | 0.00% | -5256.80% |
| ROE | N/A | -24.90% |
| ROIC | -43.41% | -26.20% |
Growth (annualized)
| Metric | BLSM | STTK |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -11.25% |
| Total return CAGR (5Y) | N/A | -20.11% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.